Loading...
Loading...
OncoGenex
Pharmaceuticals, Inc.
OGXI today announced that it has priced an
underwritten public offering of 4,165,000 shares of its common stock at a
purchase price of $12.00 per share. Net proceeds, after estimated
underwriting discounts and commissions and estimated expenses, will be
approximately $46.8 million. OncoGenex granted the underwriters a 30-day
option to purchase up to an additional 624,750 shares of common stock to cover
overallotments, if any. The offering is expected to close on or about March
21, 2012, subject to customary closing conditions.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in